Literature DB >> 1719082

Epitope mapping of the Syrian hamster prion protein utilizing chimeric and mutant genes in a vaccinia virus expression system.

M Rogers1, D Serban, T Gyuris, M Scott, T Torchia, S B Prusiner.   

Abstract

The cellular prion protein (PrPc) is a host-encoded sialoglycoprotein bound to the external surface of the cell membrane by a glycosyl phosphatidylinositol anchor. A posttranslationally modified PrP isoform (PrPSc) is a component of the infectious particle causing scrapie and the other prion diseases. mAb have been raised against the protease-resistant core of Syrian hamster (SHa) PrPSc designated PrP 27-30. To map the epitopes within PrP reacting to these antibodies, we have expressed wild-type, chimeric mouse (Mo)/SHa and mutant MoPrP genes using recombinant vaccinia virus systems. The fidelity of the expression of recombinant PrPC was examined using vaccinia viruses expressing SHa-PrPC. It is full length, possesses Asn-linked carbohydrates and is attached to the external surface of the cell membrane by a glycosyl phosphatidylinositol anchor that is sensitive to cleavage by phosphatidylinositol-specific phospholipase C. We have tested 18 mAb for their ability to bind to chimeric prion proteins on immunoblots. Three distinct epitopes were identified that mapped to amino acid differences between SHa and MoPrP sequences. The first epitope, recognized by three of the antibodies tested, was defined by methionines at amino acids 108 and 111 in the mouse protein. The second epitope was dependent upon the presence of asparagines at positions 154 and 174 in MoPrP and was recognized by four of the antibodies tested. The third epitope mapped to a single amino acid substitution at residue 138 in MoPrP. mAb raised against SHaPrP 27-30 specific for this epitope are able to bind MoPrPC which has a single amino acid change (Ile to Met) at position 138. Eleven of the 18 antibodies tested mapped to this immunodominant epitope. It is located within a postulated amphipathic helix, a structure associated with immunodominant Ag. Inasmuch as PrPC, in its native form on the cell surface, is detected by the mAb 13A5 (a prototypic antibody of the immunodominant third epitope class), it is likely that this epitope is accessible in the native conformation of this protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719082

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Dominant-negative inhibition of prion formation diminished by deletion mutagenesis of the prion protein.

Authors:  L Zulianello; K Kaneko; M Scott; S Erpel; D Han; F E Cohen; S B Prusiner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Mimicking dominant negative inhibition of prion replication through structure-based drug design.

Authors:  V Perrier; A C Wallace; K Kaneko; J Safar; S B Prusiner; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Cotranslational partitioning of nascent prion protein into multiple populations at the translocation channel.

Authors:  Soo Jung Kim; Ramanujan S Hegde
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

4.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

5.  Regional mapping of prion proteins in brain.

Authors:  A Taraboulos; K Jendroska; D Serban; S L Yang; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

6.  Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.

Authors:  R A Williamson; D Peretz; N Smorodinsky; R Bastidas; H Serban; I Mehlhorn; S J DeArmond; S B Prusiner; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

7.  Creutzfeldt-Jakob disease associated with an R148H mutation of the prion protein gene.

Authors:  Bjarne Krebs; Rosa-Maria Lederer; Otto Windl; Eva-Maria Grasbon-Frodl; Inga Zerr; Hans A Kretzschmar
Journal:  Neurogenetics       Date:  2005-03-18       Impact factor: 2.660

8.  Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.

Authors:  K Kaneko; D Peretz; K M Pan; T C Blochberger; H Wille; R Gabizon; O H Griffith; F E Cohen; M A Baldwin; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  An antibody raised against a conserved sequence of the prion protein recognizes pathological isoforms in human and animal prion diseases, including Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.

Authors:  P Piccardo; J P Langeveld; A F Hill; S R Dlouhy; K Young; G Giaccone; G Rossi; M Bugiani; O Bugiani; R H Meloen; J Collinge; F Tagliavini; B Ghetti
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

10.  Three scrapie prion isolates exhibit different accumulation patterns of the prion protein scrapie isoform.

Authors:  S J DeArmond; S L Yang; A Lee; R Bowler; A Taraboulos; D Groth; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.